These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18020970)

  • 21. Homocysteine, another risk factor for Alzheimer disease, impairs apolipoprotein E3 function.
    Minagawa H; Watanabe A; Akatsu H; Adachi K; Ohtsuka C; Terayama Y; Hosono T; Takahashi S; Wakita H; Jung CG; Komano H; Michikawa M
    J Biol Chem; 2010 Dec; 285(49):38382-8. PubMed ID: 20889503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport.
    Julve J; Escolà-Gil JC; Rodríguez-Millán E; Martín-Campos JM; Jauhiainen M; Quesada H; Rentería-Obregón IM; Osada J; Sánchez-Quesada JL; Blanco-Vaca F
    Mol Nutr Food Res; 2013 Oct; 57(10):1814-24. PubMed ID: 23754667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism.
    Villa P; Perri C; Suriano R; Cucinelli F; Panunzi S; Ranieri M; Mele C; Lanzone A
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4622-9. PubMed ID: 15899950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cysteinemia, rather than homocysteinemia, is associated with plasma apolipoprotein A-I levels in hyperhomocysteinemia: lipid metabolism in cystathionine beta-synthase deficiency.
    Nuño-Ayala M; Guillén N; Navarro MA; Lou-Bonafonte JM; Arnal C; Gascón S; Barranquero C; Godino J; Royo-Cañas M; Sarría AJ; Guzmán MA; Hernandez E; Bregante MA; García-Gimeno MA; Osada J
    Atherosclerosis; 2010 Sep; 212(1):268-73. PubMed ID: 20537649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic acid (LY518674), that produces marked changes in serum lipids and apolipoprotein A-1 expression.
    Singh JP; Kauffman R; Bensch W; Wang G; McClelland P; Bean J; Montrose C; Mantlo N; Wagle A
    Mol Pharmacol; 2005 Sep; 68(3):763-8. PubMed ID: 15933217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PKM2-dependent metabolic reprogramming in CD4
    Lü S; Deng J; Liu H; Liu B; Yang J; Miao Y; Li J; Wang N; Jiang C; Xu Q; Wang X; Feng J
    J Mol Med (Berl); 2018 Jun; 96(6):585-600. PubMed ID: 29732501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?
    Paganelli F; Mottola G; Fromonot J; Marlinge M; Deharo P; Guieu R; Ruf J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between serum amyloid A and apolipoprotein A-I in high-density lipoprotein isolated from patients with coronary heart disease.
    Wang DX; Liu H; Yan LR; Zhang YP; Guan XY; Xu ZM; Jia YH; Li YS
    Chin Med J (Engl); 2013; 126(19):3656-61. PubMed ID: 24112159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-density lipoproteins: multifunctional vanguards of the cardiovascular system.
    Marcil M; O'Connell B; Krimbou L; Genest J
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):417-30. PubMed ID: 15151487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperhomocysteinemia and hyperandrogenemia share PCSK9-LDLR pathway to disrupt lipid homeostasis in PCOS.
    Mondal K; Chakraborty P; Kabir SN
    Biochem Biophys Res Commun; 2018 Sep; 503(1):8-13. PubMed ID: 29660344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis.
    Fang P; Zhang D; Cheng Z; Yan C; Jiang X; Kruger WD; Meng S; Arning E; Bottiglieri T; Choi ET; Han Y; Yang XF; Wang H
    Diabetes; 2014 Dec; 63(12):4275-90. PubMed ID: 25008174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraoxonase 1 and homocysteine metabolism.
    Perła-Kaján J; Jakubowski H
    Amino Acids; 2012 Oct; 43(4):1405-17. PubMed ID: 22643843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyperhomocysteinemia: atherothrombosis and neurotoxicity].
    Fridman O
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(1):21-30. PubMed ID: 10797837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic high-density lipoprotein secretion regulates the mobilization of cell-surface hepatic lipase.
    Chatterjee C; Young EK; Pussegoda KA; Twomey EE; Pandey NR; Sparks DL
    Biochemistry; 2009 Jun; 48(25):5994-6001. PubMed ID: 19425605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative Correlation Between Serum Levels of Homocysteine and Apolipoprotein M.
    Wei J; Yu Y; Feng Y; Zhang J; Jiang Q; Zheng L; Zhang X; Xu N; Luo G
    Curr Mol Med; 2019; 19(2):120-126. PubMed ID: 30854963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Role of HDL in Cholesterol Efflux and Reverse Cholesterol Transport].
    Ayaori M
    Rinsho Byori; 2016 Jan; 64(1):57-65. PubMed ID: 27192798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
    Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI
    Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperhomocysteinemia, DNA methylation and vascular disease.
    Jamaluddin MS; Yang X; Wang H
    Clin Chem Lab Med; 2007; 45(12):1660-6. PubMed ID: 18067449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.